Aug 12, 2025 7:47am EDT Intensity Therapeutics, Inc. Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement
Aug 7, 2025 4:06pm EDT Intensity Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update